The National Institutes of Health (NIH), as part of the U.S. Department of Health and Human Services, is the nation’s major clinical research agency and the world’s largest funder of biomedical research.

The National Institute of Mental Health (NIMH) is an institute within the NIH dedicated to funding basic and clinical research on mental illness and developing solutions for their prevention, recovery, and cure.

The Massachusetts General Hospital Research Scholars program provides financial support to innovative researchers endeavoring into uncharted areas of study.

The Tommy Fuss Fund is a private foundation established by the Fuss family in memory of their son to support medical research on mental illness and methods of diagnosing and treating it. In addition to research, the foundation is working to promote awareness of mental illness and remove its stigmas.

Inspired by the memory of Demarest Lloyd Jr., this foundation was established by his daughter Tangley Lloyd to support research in psychiatry, pediatrics, and various programs immensely benefiting those in need.

Based in Cambridge and Boston, Massachusetts, Harvard University is devoted to excellence in teaching, learning, and research for undergraduate, graduate, and professional students.

Consisting of more than 3,000 researchers, Boston Children’s Hospital is a pediatric center devoted to providing world-class care to large, diverse patient populations and conducting innovative research on various diseases, common and rare.

Based in the Broad Institute of MIT and Harvard, the Stanley Center for Psychiatric Research studies psychiatric disorders with an acute emphasis on genetics, interdisciplinary neurobiology and model systems, and therapeutics.

The Psychiatric Genomics Consortium consolidates the efforts of 800+ researchers from 36 countries to conduct meta- and mega-analyses of genome-wide genomic data for psychiatric disorders.

The UK Biobank is a cohort study with extensive genetic, physical, and health data collected from ~500,000 individuals in the United Kingdom from 2006-2010. These datasets have been made openly accessible to promote larger genetic and epidemiological studies of various health related traits.

Organized and funded by the NIH, the eMERGE Network is an interdisciplinary consortium of researchers conducting research in genomics, primarily through combining biorepositories with electronic health record systems.

The All of Us Research Program seeks to expand precision medicine to all diseases by building a national large-scale cohort of one million or more participants in the US.

By collecting small blood samples from research participants across the vast Partners Healthcare System, the Biobank enables researchers to study links between genetics, family history, and environment in the pathophysiology and treatment of diseases.

The Center for Genomic Medicine (CGM) is leading efforts to uncover genomic underpinnings of diseases and translate discoveries to nuanced methods of disease diagnosis, management, and treatment.

The Analytic and Translational Genetics Unit (ATGU) at MGH works in partnership with the Broad Institute to interpret genome sequence data for the discovery of genetic underpinnings of human disease and for the development of paradigms by which individuals’ genome sequence can be effectively integrated into clinical decision making.

Based in Ann Arbor, The University of Michigan is comprised of 19 schools and colleges all promoting collaboration and interdisciplinary research efforts involving faculty and students.

Located in Nashville, Vanderbilt University is a private research university committed to excellence in research and education with its faculty and students in its 10 schools.

The ENIGMA Consortium is an international collaboration that uses imaging, genomics, neurology, and psychiatry to understand brain structure and function.

Consisting of Massachusetts General Hospital, University of Southern California, Cardiff University, and Karolinska Institute, the ICCBD studies the genetics of bipolar disorder by developing and applying high-throughput phenotyping methods and conducting genomewide association analyses.